ACTEON
Acquired by
BRIDGEPOINT / RAISE / FLEXSTONE PARTNERS
ACTEON acquired by BRIDGEPOINT / RAISE / FLEXSTONE PARTNERS
Target
ACTEON
Acquirer
BRIDGEPOINT / RAISE / FLEXSTONE PARTNERS
Context
The third LBO of Acteon marks a definitive strategic shift toward institutional global leadership, orchestrated by Bridgepoint Development Capital alongside Raise Investissement and Euro Private Equity. The strategic rationale for this transaction centers on an "innovation-acceleration" play, merging the group’s industry-leading technical operational depth in ultrasonics with the sponsor’s extensive international commercial infrastructure. This structural alignment provides the organization with the scientific talent and logistical hardware required to address the increasing complexity of the global digital dentistry market. This operation allows the group to execute a definitive structural expansion of its product suite, particularly through a renewed emphasis on research and development following several years of stabilization. By incorporating the sponsor’s strategic discipline, the group is now positioned to leverage its recognized leadership in high-frequency imaging to deepen its presence in high-stakes markets such as North America and Asia.
This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 13.3x since the beginning of 2026, 1.5% decrease compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Acteon is a France company specialized in Dental Technology. The organization has built its name as a high-fidelity provider of specialized medical devices, particularly leading the field in ultrasound surgery and digital medical imaging. Instead of producing generic dental tools, they thrive on a philosophy of clinical precision, offering innovative hardware that enables dentists and surgeons to perform minimally invasive procedures with superior imaging clarity. Their growth is currently fueled by a rigorous focus on new product development, a shift that has allowed them to break out of historical stagnation and capture significant market share in fast-growing dental tech segments.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with ACTEON
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 08/2018 | DENTRESSANGLE | ACTEON | FRANCE | Medical Devices | The acquisition of Acteon by Dentressangle represents a major turning point in the medtech’s trajectory, moving toward an aggressive buy-and-build strategy. The strategic rationale for this transaction centers on an "industrial-consolidation" play, merging the group’s industry-leading technical operational depth in ultrasonic surgery with the sponsor’s extensive expertise in executing international build-up operations. This structural alignment provides the organization with the institutional capital and strategic guidance required to address the increasing demand for integrated dental technology suites. This operation allows the group to execute a definitive structural expansion of its product portfolio by identifying specialized family-owned companies to complement its imaging and hardware lines. By incorporating the sponsor’s strategic discipline, the group is now positioned to leverage its recognized leadership in the United States, China, and Japan to drive deeper market penetration. The maneuver optimizes the group’s financial profile, utilizing a robust unitranche facility provided by Capzanine to fund an ambitious roadmap of external growth. Ultimately, the partnership solidifies the group’s standing as a primary enabler of medtech innovation, bridging the gap between sophisticated laboratory-scale imaging science and industrialized clinical manufacturing standards. |
| 01/2006 | EDMOND DE ROTHSCHILD CAPITAL PARTNERS | ACTEON | FRANCE | Medical Devices | Acteon is a France company specialized in Dental Technology. The organization has built its name as a high-fidelity provider of specialized medical devices, particularly leading the field in ultrasound surgery and digital medical imaging. Instead of producing generic dental tools, they thrive on a philosophy of clinical precision, offering innovative hardware that enables dentists and surgeons to perform minimally invasive procedures with superior imaging clarity. Their growth is currently fueled by a rigorous focus on new product development, a shift that has allowed them to break out of historical stagnation and capture significant market share in fast-growing dental tech segments. |
mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.